1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Mental Health

Mental Health: Latest Statistics & Complete Sector Overview

  • Currently 0/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
0 vote

Global Mental Health Sector Statistics

The industry of mental health treatment and analysis is a sub-category of the pathology industry. According to the World Health Organisation the definition of a mental health problem is a psychological state preventing an individual from realizing his or her own potential, coping with the normal stresses of life, working productively and fruitfully, and being able to make a contribution to her or his community.

Mental health disorders can be treated and managed, but not always cured. Symptoms related to mental health illness can be managed with a combination of medication and behavioral therapies. Mental disorders are highly prevalent.

Approximately one in five people suffer from some form of mental illness globally. In the foreseeable future behavioral health disorders will surpass all physical diseases as a major cause of disability worldwide. By 2030, mental disorders are estimated to cost the global economy around $6 trillion a year.

Key Segments

The major categories of mental health disorders are:

Anxiety disorders – Excessive or inappropriate states of arousal characterized by feelings of apprehension, uncertainty or fear. Anxiety disorders are the most common mental health disorders. Common anxiety disorders are generalized anxiety disorders and panic disorders. The treatment rate of anxiety disorders is low: Only about one-third of anxiety patients receive treatment.

Mood disorders – Distortions of the general emotional state. Depression, bipolar disorder and seasonal affective disorder are common mood disorders. Mood disorders are highly prevalent. Globally around 350 million people suffer from depression.

Schizophrenia disorders – Serious brain disorders characterized by profound disruption in cognition and emotion. They affect fundamental human attributes such as language, thoughts, perceptions, affect and sense of self. Schizophrenia can be treated and managed but cannot be cured. It affects more than 20 million people worldwide.

Dementias – Disturbances of consciousness and changes in cognition. Dementia is caused by damage to brain cells. Currently available drug therapies can temporarily improve symptoms of the disease but cannot cure it. According to WHO, the number of people living with dementia is estimated to increase to about 75 million by 2030.

Eating disorders – Illness characterized by irregular eating habits and severe distress about body’s structure. Common eating disorders include anorexia nervosa, bulimia nervosa, and binge-eating disorder. Eating disorders affect up to 70 million individuals worldwide. China, India and the USA are the countries with the highest rates of eating disorders in the world.

Regional Market Shares

Major regions for mental health treatment include North America, Europe and Asia.

In North America more than 10 million adults suffer from a weakening mental illness. Mental health disorders are one of the leading causes of disability in the USA and Canada, accounting for 25% of all years of life lost to disability and premature mortality. Mental disorders are among the region’s most expensive medical conditions. For instance, national expenditure for mental health care in the USA is more than $150 billion.

In Europe, mental health illnesses account for nearly 20% of diseases. More than 20% of the adult population in Norway, Switzerland and Finland experience a mental health illness which includes anxiety, depression and eating disorders. Mental health problems are a growing source of productivity loss in many EU countries. Organizations in health and non-health sectors in this region are now taking measures to make significant economic gains from investing in interventions to promote mental health and prevent mental disorders.

Read more »

Share

You might be interested in these related markets:

24/7 Customer Support

Talk to Sam

+33 4 37 65 17 06

1-10 of about 13000 reports

Global Mental Health Statistics - Forecast

  • October 2017
    10 pages
  • Mental Health  

    Mental Health  

  • World  

    Bangladesh  

    Asia  

View report >

Mental Health Statistics in the US

  • September 2017
    9 pages
  • Mental Health  

  • United States  

View report >

Mental Health Statistics in Europe

  • August 2017
    13 pages
  • Mental Health  

  • Europe  

View report >

Mental Health Statistics in the UK and Asia

  • January 2017
    14 pages
  • Mental Health  

    Psychotic Disor...  

    Mental Health  

  • United Kingdom  

    Asia  

View report >

Mental Health Statistics in Japan

  • February 2017
    6 pages
  • Mental Health  

  • Japan  

View report >

Mental Health Statistics in France

  • June 2016
    40 pages
  • Mental Health  

  • France  

View report >

Mental Health Statistics in Germany

  • May 2017
    10 pages
  • Risky Behaviour  

  • Germany  

View report >

Mental Health Statistics in Italy

  • January 2016
    10 pages
  • Mental Health  

  • Italy  

    Europe  

View report >

Mental Health Statistics in the UK

  • October 2017
    34 pages
  • Mental Health  

  • United Kingdom  

View report >

Addictions and Mental Health Statistics in Canada

  • August 2017
    8 pages
  • Addictions  

    Mental Health  

  • Canada  

    North America  

View report >

Search in Mental Health Industry (About 13000 reports)
Parent industry: Pathology
Related industries: Chronic Disease, Cancer

About 1200 reports

Purchase Reports From Reputable Market Research Publishers
(From € 135 - € 20000)

Parkinson%s disease forecast and market analysis to 2035

  • € 20000
  • Industry report
  • March 2017
  • by Datamonitor Healthcare

Sizable pipeline characterized by both high growth and attrition Parkinson’s disease is a chronic and progressive neurodegenerative disorder characterized by tremors, rigidity, bradykinesia (slowness ...

Opportunity Analyzer: Huntington’s Disease - Opportun ...

May 2016 € 9996

Pharmapoint: Schizophrenia - Global Drug Forecast And M ...

November 2016 € 9995

Pharmapoint: Major Depressive Disorder - Global Drug Fo ...

October 2016 € 9995

Pharmapoint: Attention Deficit Hyperactivity Disorder ( ...

September 2016 € 9995

Pharmafocus: Tauopathies - Global Market Analysis

February 2017 € 8632

Frontier Pharma: Diabetic Complications - Innovative An ...

June 2016 € 6359

Frontier Pharma: Alzheimer’s Disease And Associated I ...

May 2017 € 6359

Schizophrenia - 5eu Drug Forecast And Market Analysis T ...

November 2016 € 6359

Major Depressive Disorder - 5eu Drug Forecast And Marke ...

October 2016 € 6359

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.